Starburst – building order books; bright outlook (24 Aug 2020)

In May 2019, I met Starburst’s Managing and Executive Director Mr Yap Tin Foo. Since Mar 2020, Starburst has been on a roll in winning contracts and I believe it is an opportune time to meet Mr Yap again. Despite Mr Yap’s busy schedule, he agrees to meet me on 1-1 basis to share his company’s business operations and prospects. Below are some of my takeaways from my discussion with him and from its recent results briefing.   Company description Quoting from Starburst’s press release, it is an engineering specialist in a niche industry, and designs, fabricates, installs and maintains […]

10 things you must know when upgrading from HDB to private (1st October 2019)

This write-up was reproduced with permission from Ray’s Estate Clinic, written by Founder, Raymond Chng. Please refer to the end of the article for more information on Raymond. The decision to upgrade from a HDB to a private property whether a condominium or landed property is a big decision to many, over the past few years, I have had many clients ask me for my opinions and particularly if they should upgrade. Many HDB owners upgrade because they are fearful of their HDB price being stagnant. The worst thing that can happen is a HDB owner to upgrade into a […]

How to select a good unit in a new launch property that outperforms? (17 Sep 2019)

This write-up was reproduced with permission from Ray’s Estate Clinic, written by Founder, Raymond Chng. Please refer to the end of the article for more information on Raymond. Over the years, I have had the opportunity to market numerous properties in different developments, some within the same developments. What I noticed was, even within the same condominium, there are units that sell within 3-4 weeks, while some took more than 3 months. There are some units that are just more desirable by most buyers. There are also some owners that managed to make significant profits while some struggled to make […]

Sing Medical – Chart seems to be strengthening (13 Feb 2019)

This week, Sing Medical’s (“SMG”) caught my attention. At the time of writing this write-up, SMG is trading +0.005 to $0.430. Day range 0.425 – 0.430.   Some interesting observations on SMG a) Chart seems to be strengthening Based on Chart 1 below, SMG seems to have breached the near term downtrend line established since Mar 2018. Today is T+7 of the sharp upmove dated 31 Jan 2019 thus, I guess those contra players (who plan to contra and not hold the stock) have already exited. Indicators such as OBV, RSI and MACD are strengthening. ADX last trades 34.5 on […]